How members of the Society for Reproductive Endocrinology and Infertility and Society of Reproductive Surgeons evaluate, define, and manage hydrosalpinges

Kenan Omurtag*, Natalia M. Grindler, Kimberly A. Roehl, Gordon Wright Bates, Angeline N. Beltsos, Randall R. Odem, Emily S. Jungheim

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Objective: To describe the management of hydrosalpinges among Society for Reproduction Endocrinology and Infertility (SREI)/Society of Reproductive Surgeons (SRS) members. Design: Cross-sectional survey of SREI/SRS members. Setting: Academic and private practice-based reproductive medicine physicians. Participant(s): A total of 442 SREI and/or SRS members. Intervention(s): Internet-based survey. Main Outcome Measure(s): To understand how respondents evaluate, define, and manage hydrosalpinges. Result(s): Of 1,070 SREI and SRS members surveyed, 442 responded to all items, for a 41% response rate. Respondents represented both academic and private practice settings, and differences existed in the evaluation and management of hydrosalpinges. More than one-half (57%) perform their own hysterosalpingograms (HSGs), and 54.5% involve radiologists in their interpretation of tubal disease. Most respondents thought that a clinically significant hydrosalpinx on HSG is one that is distally occluded (80.4%) or visible on ultrasound (60%). Approximately one in four respondents remove a unilateral hydrosalpinx before controlled ovarian hyperstimulation (COH)/intrauterine insemination (IUI) and clomiphene citrate (CC)/IUI (29.3% and 22.8%, respectively), and physicians in private practice were more likely to intervene (COH: risk ratio [RR] 1.81, 95% confidence interval [CI] 1.31-2.51; CC: RR 1.98, 95% CI 1.33-2.95). Although laparoscopic salpingectomy was the preferred method of surgical management, nearly one-half responded that hysteroscopic tubal occlusion should have a role as a primary method of intervention. Conclusion(s): SREI/SRS members define a "clinically significant hydrosalpinx" consistently, and actual practice among members reflects American Society for Reproductive Medicine/SRS recommendations, with variation attributed to individual patient needs. Additionally, one in four members intervene before other infertility treatments when there is a unilateral hydrosalpinx present.

Original languageEnglish (US)
Pages (from-to)1095-1100.e2
JournalFertility and Sterility
Issue number5
StatePublished - May 2012
Externally publishedYes


  • ASRM
  • Hydrosalpinx
  • SREI
  • hysteroscopic tubal occlusion
  • in vitro fertilization
  • salpingectomy
  • tubal disease

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'How members of the Society for Reproductive Endocrinology and Infertility and Society of Reproductive Surgeons evaluate, define, and manage hydrosalpinges'. Together they form a unique fingerprint.

Cite this